Cellectar Biosciences, Inc.
CLRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001279704
No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.08M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Cellectar Biosciences, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 37 | 1 | 35 | −1 |
| Shares | 11.6M | 228.9K | 14.0M | +2.64M (+23.2%) |
| Value | $28.3M | $572.3K | $30.0M | +$2.29M (+8.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Cellectar Biosciences, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 232,320 | $497.2K | 0.00% |
| Altium Capital Management LP | 215,000 | $460.1K | 0.14% |
| Pale Fire Capital SE | 25,030 | $53.6K | 0.01% |
| Sequoia Financial Advisors, LLC | 23,800 | $50.9K | 0.00% |
| Two Sigma Securities, LLC | 22,799 | $48.8K | 0.00% |
| Oppenheimer & Co Inc | 12,500 | $26.8K | 0.00% |
Sold out (7)
Institutions that held Cellectar Biosciences, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Hudson Bay Capital Management LP | 150,000 | $375.0K |
| Acuta Capital Partners, LLC | 70,500 | $176.3K |
| Millennium Management LLC | 42,647 | $106.6K |
| Jane Street Group, LLC | 41,865 | $104.7K |
| Verition Fund Management LLC | 15,217 | $38.0K |
| Coastal Bridge Advisors, LLC | 11,000 | $27.5K |
| Redwood Wealth Management Group, LLC | 1,000 | $2.50K |
Not filed for Q3 2024 yet (1)
Institutions that held Cellectar Biosciences, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 228,930 | $572.3K |